Thomas Zeyen

7PUBLICATIONS
13CO-AUTHORS
Biomedical imagingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Vision scienceGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2026
Proof of concept: Portable ultra-low-field MRI for the assessment of brain tumors.

|Nov 14, 2025
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma.

Thomas Zeyen, Inga Krause, Andreas Decker

|Jun 27, 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safety.

Thomas Zeyen, Antonia Treiber, Matthias Schneider

|May 16, 2025
Cerebellar Hemorrhage Masquerading as Unilateral Vestibulopathy: A Case Report.

Thomas Zeyen, Thomas Klockgether, Christina Schaub

|Feb 04, 2025
High-dose MTX-based polychemotherapy for primary CNS lymphoma in younger patients: Long-term efficacy of the modified Bonn protocol.

Thomas Zeyen, Johannes Weller, Matthias Schneider

|Nov 15, 2024
Gene expression signature-defined necroinflammation is not associated with sex-biased survival or bevacizumab benefit in glioblastoma.

Johannes Weller, Emre Kocakavuk, Barbara Pregler

Pageof 2

Frequent Collaborators

4 joint publications

Matthias Schneider

4 joint publications

Johannes Weller

3 joint publications

Anna-Laura Potthoff

2 joint publications

Daniel Paech